These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2079074)

  • 1. Growth hormone deficiency of hypothalamic origin in septo-optic dysplasia.
    Yukizane S; Kimura Y; Yamashita Y; Matsuishi T; Horikawa H; Ando H; Yamashita F
    Eur J Pediatr; 1990 Nov; 150(1):30-3. PubMed ID: 2079074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine disorders in septo-optic dysplasia (De Morsier syndrome)--evaluation and follow up of 18 patients.
    Willnow S; Kiess W; Butenandt O; Dorr HG; Enders A; Strasser-Vogel B; Egger J; Schwarz HP
    Eur J Pediatr; 1996 Mar; 155(3):179-84. PubMed ID: 8929724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why is the retention of gonadotrophin secretion common in children with panhypopituitarism due to septo-optic dysplasia?
    Nanduri VR; Stanhope R
    Eur J Endocrinol; 1999 Jan; 140(1):48-50. PubMed ID: 10037251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sexual precocity in association with septo-optic dysplasia and hypothalamic hypopituitarism.
    Huseman CA; Kelch RP; Hopwood NJ; Zipf WB
    J Pediatr; 1978 May; 92(5):748-53. PubMed ID: 205644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone-releasing hormone in the diagnosis and treatment of growth hormone deficient children.
    Ross RJ; Grossman A; Besser GM; Savage MO
    Acta Endocrinol Suppl (Copenh); 1986; 279():123-9. PubMed ID: 3096037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Behavior of growth hormone after stimulation with growth hormone releasing hormone (GHRH) in children with disorders of the hypothalamo-hypophyseal axis and girls with Turner syndrome].
    Schmitt K; Schober E; Birnbacher R; Frisch H
    Klin Padiatr; 1996; 208(1):29-34. PubMed ID: 8851324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a hypothalamic defect in septo-optic dysplasia.
    Wilson PW; Easley RB; Bolander FF; Hammond CB
    Arch Intern Med; 1978 Aug; 138(8):1276-7. PubMed ID: 677986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital optic nerve hypoplasia with hypothalamic-pituitary dysplasia. A review of 16 cases.
    Margalith D; Tze WJ; Jan JE
    Am J Dis Child; 1985 Apr; 139(4):361-6. PubMed ID: 3976626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective growth hormone deficiency of hypothalamic origin following severe head injury.
    Lopez Guzman A; Salvador J; Albero R; Sastre J; Iglesias P; Diez JJ; Gomez-Pan A
    Acta Paediatr; 1992 Sep; 81(9):698-9. PubMed ID: 1421912
    [No Abstract]   [Full Text] [Related]  

  • 10. Sexual precocity with hypothalamic hypopituitarism.
    LaFranchi SH
    Am J Dis Child; 1979 Jul; 133(7):739-42. PubMed ID: 223432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Septo-optic dysplasia.
    Fard MA; Wu-Chen WY; Man BL; Miller NR
    Pediatr Endocrinol Rev; 2010 Sep; 8(1):18-24. PubMed ID: 21037540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the morphological evaluation of the pituitary and the growth hormone (GH) response to GH-releasing hormone Plus arginine in children and adults with congenital hypopituitarism.
    Maghnie M; Salati B; Bianchi S; Rallo M; Tinelli C; Autelli M; Aimaretti G; Ghigo E
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1574-9. PubMed ID: 11297586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The syndrome of septo-optic dysplasia in Saudi children.
    Bin-Abbas BS; Al-Ashwal AA; Al-Alwan IA; Al-Qahtani MH; Al-Mutair AN; Sakati NA
    Saudi Med J; 2004 Nov; 25(11):1675-8. PubMed ID: 15573200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal, metabolic, and neuroradiologic abnormalities associated with septo-optic dysplasia.
    Arslanian SA; Rothfus WE; Foley TP; Becker DJ
    Acta Endocrinol (Copenh); 1984 Oct; 107(2):282-8. PubMed ID: 6093418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transection.
    Pombo M; Barreiro J; Peñalva A; Peino R; Dieguez C; Casanueva FF
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3180-4. PubMed ID: 7593423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Septo-optic dysplasia and growth hormone deficiency: accelerated pubertal maturation during GH therapy.
    Freude S; Frisch H; Wimberger D; Schober E; Hüsler G; Waldhauser F; Aichner F
    Acta Paediatr; 1992 Aug; 81(8):641-5. PubMed ID: 1392395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth-hormone-releasing hormone.
    Vance ML
    Clin Chem; 1990 Mar; 36(3):415-20. PubMed ID: 2107038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Puberty in the syndrome of septo-optic dysplasia.
    Hanna CE; Mandel SH; LaFranchi SH
    Am J Dis Child; 1989 Feb; 143(2):186-9. PubMed ID: 2916489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone releasing hormone priming increases growth hormone secretion in patients with Cushing's syndrome.
    Leal-Cerro A; Pumar A; Villamil F; Astorga R; Dieguez C; Casanueva FF
    Clin Endocrinol (Oxf); 1993 Apr; 38(4):399-403. PubMed ID: 8319372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypopituitarism and neurodevelopmental abnormalities in relation to central nervous system structural defects in children with optic nerve hypoplasia.
    Haddad NG; Eugster EA
    J Pediatr Endocrinol Metab; 2005 Sep; 18(9):853-8. PubMed ID: 16279362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.